Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients

Journal of NeuroVirology

Volumn 10, Issue SUPPL. 1, 2004, Pages 7-14

  Burdo, Tricia H ^a,d   Gartner, Suzanne ^b   Mauger, David ^a   Wigdahl, Brian ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

C EBP; HIV 1; HIV 1 associated dementia; LTR; Sequence variation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; NUCLEOTIDE;

ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD; BRAIN REGION; BRAIN TISSUE; CELL TYPE; CEREBELLUM; CONTROLLED STUDY; DEMENTIA; FRONTAL LOBE; GENE EXPRESSION; GENE LOCATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LATENT VIRUS INFECTION; LONG TERMINAL REPEAT; MONOCYTE; PRIORITY JOURNAL; PROVIRUS; STATISTICAL SIGNIFICANCE; VIRUS GENE; VIRUS REPLICATION;

AIDS DEMENTIA COMPLEX; BRAIN; CCAAT-ENHANCER-BINDING PROTEINS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; TRANSCRIPTION FACTOR CHOP; TRANSCRIPTION FACTORS; TRANSFECTION; U937 CELLS; VARIATION (GENETICS); VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 1542315473     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280490270789     Document Type: Article

References (30)

1. Agresti A (1990). Categorical data analysis. New York: John Wiley and Sons.
2. Ait-Khaled M, Emery VC (1994). Phylogenetic relationship between human immunodeficiency virus type 1 (HIV-1) long terminal repeat natural variants present in the lymph node and peripheral blood of three HIV-1-infected individuals. J Gen Virol 75: 1615-1621.
3. Ait-Khaled M, McLaughlin JE, Johnson MA, Emery VC (1995). Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. AIDS 9: 675-683.
4. Brew BJ, Pemberton L, Cunningham P, Law MG (1997). Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 175: 963-966.
5. Chang J, Jozwiak R, Wang B, Ng T, Ge YC, Bolton W, Dwyer DE, Randle C, Osborn R, Cunningham AL, Saksena NK (1998). Unique HIV type 1 V3 region sequences derived from six different regions of brain: region-specific evolution within host-determined quasispecies. AIDS Res Hum Retroviruses 14: 25-30.
6. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, Young SA, Mills RG, Wachsman W, Wiley CA (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42: 1736-1739.
7. Dignam JD, Lebovitz RM, Roeder RG (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489.
8. Epstein LG, Kuiken C, Blumberg BM, Hartman S, Sharer LR, Clement M, Goudsmit J (1991). HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies. Virology 180: 583-590.
9. Fujimura RK, Goodkin K, Petito CK, Douyon R, Feaster DJ, Concha M, Shapshak P (1997). HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia. J Acquir Immune Defic Syndr Hum Retrovirol 16: 146-152.
10. Gartner S (2000). HIV infection and dementia. Science 287: 602-604.
11. Gartner S, McDonald RA, Hunter EA, Bouwman F, Liu Y, Popovic M (1997). Gp120 sequence variation in brain and in T-lymphocyte human immunodeficiency virus type 1 primary isolates. J Hum Virol 1: 3-18.
12. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 38: 755-762.
13. Henderson AJ, Calame KL (1997). CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells. Proc Natl Acad Sci U S A 94: 8714-8719.
14. Henderson AJ, Connor RI, Calame KL (1996). C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5: 91-101.
15. Henderson AJ, Zou X, Calame KL (1995). C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 69: 5337-5344.
16. Hogan TH, Krebs FC, Wigdahl B (2002). Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage. J NeuroVirol 8 (Suppl 2): 21-26.
17. Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B (2003a). HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomed Pharmacother 57: 44-51.
18. Hogan TH, Stauff D, Krebs FC, Gartner S, Quiterio S, Wigdahl B (2003b). Structural and functional evolution of HIV-1 LTR C/EBP sites and their use as molecular markers for CNS disease progression. J NeuroVirol 9: 1-14.
19. Korber BT, Kunstman KJ, Patterson BK, Furtado M, McEvilly MM, Levy R, Wolinsky SM (1994). Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 68: 7467-7481.
20. Krebs FC, Hogan TH, Quiterio SJ, Gartner S, Wigdahl B (2001). Lentiviral LTR-directed expression, sequence variation, and disease pathogenesis. In: HIV Sequence Conpendium 2001. Kuiken CL, Foley B, Hahn B, Korber B, McCutchan F, Marx PA, Mellors JW, Sodroski J, Wolinksy S (eds). Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, pp 1-42.
21. Liu Y, Tang XP, McArthur JC, Scott J, Gartner S (2000). Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol 6 (Suppl 1): S70-S81.
22. Major EO, Rausch D, Marra C, Clifford D (2000). HIV-associated dementia. Science 288: 440-442.
23. McClernon DR, Lanier R, Gartner S, Feaser P, Pardo CA, St Clair M, Liao Q, McArthur JC (2001). HIV in the brain: RNA levels and patterns of zidovudine resistance. Neurology 57: 1396-1401.
24. Palmer DL, Hjelle BL, Wiley CA, Allen S, Wachsman W, Mills RG, Davis LE, Merlin TL (1994). HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells. Am J Med 97: 289-295.
25. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Perryman S, Chesebro B (1994). Demented and non-demented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 68: 4643-4649.
26. Reddy RT, Achim CL, Sirko DA, Tehranchi S, Kraus FG, Wong-Staal F, Wiley CA (1996). Sequence analysis of the V3 loop in brain and spleen of patients with HIV encephalitis. AIDS Res Hum Retroviruses 12: 477-482.
27. Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B (2001a). HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J NeuroVirol 7: 235-249.
28. Ross HL, Nonnemacher MR, Hogan TH, Quiterio SJ, Henderson A, McAllister JJ, Krebs FC, Wigdahl B (2001b). Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage. J Virol 75: 1842-1856.
29. Shapshak P, Segal DM, Crandall KA, Fujimura RK, Zhang BT, Xin KQ, Okuda K, Petito CK, Eisdorfer C, Goodkin K (1999). Independent evolution of HIV type 1 in different brain regions. AIDS Res Hum Retroviruses 15: 811-820.
30. Zink WE, Zheng J, Persidsky Y, Poluektova L, Gendelman HE (1999). The neuropathogenesis of HIV-1 infection. FEMS Immunol Med Microbiol 26: 233-241.